FDA Inspection
NPS Pharmaceuticals Inc.NPS Pharmaceuticals Inc. – FDA Inspection, Dec 4, 2012
Record Details
This FDA Inspection record concerns NPS Pharmaceuticals Inc., with an inspection on December 4, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- NPS Pharmaceuticals Inc.
- Inspection Date
- December 4, 2012
- Product Type
- Drugs
View Company Profile
ID · 7c0c5a3e-f5f9-4514-9e0f-ed28bf55aae8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 809472
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.59Unused drug disposition (sponsor)
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.53(c)(4)Financial information - sufficient and accurate
- 21 CFR 312.52(a)Transfer of obligations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NPS Pharmaceuticals Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 25, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for NPS Pharmaceuticals Inc.
- FDA Inspection 887609 - 2014-07-16
- FDA Inspection 881969 - 2014-04-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.